Search
forResearch 10 of 53
- LB1007 Systemic treatment with a KLK5 inhibitor shows efficacy in a murine model of Netherton syndrome
- 267 Single- and multiple-ascending dose studies of DS-2325a, a KLK5 inhibitor for the treatment of Netherton syndrome
- LB1256 TRIV-509, a dual inhibitor of KLK5 and KLK7, rapidly improves barrier integrity and markers of epidermal differentiation in atopic dermatitis skin explants
- New developments in the molecular treatment of ichthyosis: review of the literature
- Netherton Syndrome
- KLK5 and KLK7 Ablation Fully Rescues Lethality of Netherton Syndrome-Like Phenotype
- A 20-year retrospective clinicopathologic study on melanoma in Singapore
- Nagashima-Type Palmoplantar Keratosis: A Common Asian Type Caused by SERPINB7 Protease Inhibitor Deficiency
- 565 Cutaneous delivery of LEKTI via an engineered strain of staphylococcus epidermidis for the treatment of netherton syndrome
- Netherton syndrome subtypes share IL-17/IL-36 signature with distinct IFN-α and allergic responses
Learn
— no results
Try a deeper search in learn →Community
— no results
Try a deeper search in community →